Pediatric Trials Network. March 27, 2014. A project of the Best Pharmaceuticals for Children Act. Why are studies in children difficult?. Limited number of patients with the disease No “healthy child/baby volunteer” Low rates of parental informed consent Perceived study risks
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Pediatric Trials Network
March 27, 2014
A project of the Best Pharmaceuticals for Children Act
“Create an infrastructure for investigators to conduct trials that improve pediatric labeling and child health.”